Healthcare -
Medical - Diagnostics & Research - NASDAQ - US
$ 43.38
1.95 %
$ 5.35 B
Market Cap
-12.19
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Guardant Health, Inc.
| Revenue | 739 M |
| Cost Of Revenue | 0 |
| Gross Profit | 739 M |
| Operating Expenses | 893 M |
| Operating Income | -444 M |
| Other Expenses | -7.22 M |
| Net Income | -436 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 739.0 | 563.9 | 449.5 | 373.7 | 286.7 | 214.4 | 90.6 | 49.8 | 25.2 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0 | 227.1 | 156.3 | 122.9 | 92.5 | 70.7 | 43.2 | 31.6 | 22.1 |
| Gross Profit | 739.0 | 336.9 | 293.2 | 250.7 | 194.2 | 143.7 | 47.4 | 18.2 | 3.1 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 892.8 | 901.6 | 837.6 | 661.7 | 449.1 | 226.0 | 140.4 | 94.8 | 47.0 |
| Selling, General and Administrative Expenses | 545.1 | 451.0 | 463.8 | 398.5 | 299.3 | 139.7 | 89.7 | 69.3 | 36.1 |
| Research and Development Expenses | 347.8 | 367.2 | 373.8 | 263.2 | 149.9 | 86.3 | 50.7 | 25.6 | 10.9 |
| Operating Income | (443.6) | (564.7) | (544.4) | (411.0) | (254.9) | (82.4) | (92.9) | (76.6) | (43.8) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | (2.6) | 2.6 | 2.6 | 2.6 | 4.8 | 1.2 | 1.3 | 2.7 | 3.0 |
| Total Other Income | 8.5 | 86.0 | (109.1) | 26.5 | 9.0 | 12.6 | 8.7 | (6.6) | (2.3) |
| Pre-Tax Income | (435.1) | (478.8) | (653.4) | (384.5) | (245.9) | (69.7) | (84.2) | (83.2) | (46.1) |
| NET INCOME | |||||||||
| Tax Provision | 1.3 | 0.7 | 1.1 | 0.3 | 0.4 | (1.9) | 38 K | 7 K | 6 K |
| Net Income | (436.4) | (479.4) | (654.6) | (384.8) | (246.3) | (67.9) | (85.1) | (83.2) | (46.1) |
| EPS | 3.56 | 4.28 | 6.41 | 3.8 | 2.53 | 0.75 | 2.8 | 1.18 | 0.65 |